Stock Price Forecast

April 26, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading CareDx, Inc. chart...

About the Company

We do not have any company description for CareDx, Inc. at the moment.

Exchange

Nasdaq

$363M

Total Revenue

686

Employees

$389M

Market Capitalization

-2.58

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CDNA News

CareDx Appoints John W. Hanna as its New President and Chief Executive Officer

12d ago, source:

The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant ...

How CareDx (CDNA) Stock Stands Out in a Strong Industry

28d ago, source: Nasdaq

One stock that might be an intriguing choice for investors right now is CareDx, Inc CDNA. This is because this security in the Medical Services space is seeing solid earnings estimate revision ...

CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting

20d ago, source: Stockhouse

CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value ...

CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last?

11d ago, source:

CareDx (CDNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

9d ago, source:

The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

CareDx Appoints John W. Hanna as its New President and Chief Executive Officer

13d ago, source: Morningstar

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated ...

CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting

20d ago, source: Nasdaq

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...